# RELENZA
> **NDA021036** · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1999-07-26
## Drug
- **FDA Application Number:** NDA021036
- **Application type:** New Drug Application
- **Brand name:** RELENZA
- **Generic name:** ZANAMIVIR
- **Active ingredients:** ZANAMIVIR
- **Dosage form:** POWDER
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE
- **Manufacturer:** GlaxoSmithKline LLC
- **First approval:** 1999-07-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021036)
---
*AI Analytics · CC0 1.0*